Psyence Biomedical (PBM) surged over 185% in pre-market trading, signaling a strong recovery for the beaten-down biotech stock. The massive weekly gain mirrors a similar rally seen in late 2024, catching investor attention. Competitor Viking Therapeutics (VKTX) also rallied 10%, trading near 52-week highs following its recent earnings beat.